australia's next csl?, page-35

G'day Everyone,

Am I reading too much into the latest announcement (albeit just a "humble" Appendix B)?

I assume that TIS's consultant Mr Geoff Morris is on some form of performance contract. His consultancy services (as per the Appendix B) include:-

the selection of potential commercial partners;

the development of negotiating strategies; and

the facilitation of negotiations (with such commercial partners).

One would assume that the 55,511 Ordinary Shares issued to Mr Morris today by TIS are as a result of him meeting identified performance "hurdles". I also note that the securities issued are for "the period to 31st March 2011." (which has given TIS ample time to judge if such "hurdles" have been met).

It seems to me that we possibly already have our chosen commercial partner "waiting in the wings" for the latest VitroGro trials to conclude/report (scheduled for end June 2011) and perhaps for any outstanding patent or device applications that need to be "stitched up".

I'm looking forward to July 2011 with restrained excitement even though our current market environment is "not too flash".


Regards,

Goggo

DYOR